Inuvi Diagnostics Limited
Annual Report and Financial Statements
For the year ended 31 December 2025
Company Registration No. 11304862 (England and Wales)
Inuvi Diagnostics Limited
Company Information
Directors
J Benton
T Woolley
E Schmidt-Chiari
S Paterson
(Appointed 24 September 2025)
Secretary
S Paterson
Company number
11304862
Registered office
Unit 10 Millars Brook Business Park
Molly Millars Lane
Wokingham
Berkshire
United Kingdom
RG41 2AD
Auditor
Moore Kingston Smith LLP
Orbital House
20 Eastern Road
Romford
Essex
RM1 3PJ
Inuvi Diagnostics Limited
Directors' Report
For the year ended 31 December 2025
Page 1
The directors present their annual report and financial statements for the year ended 31 December 2025.
Principal activities
The principal activity of the company continued to be that of laboratory testing.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
J Benton
T Woolley
E G Nicholson
(Resigned 30 May 2025)
E Schmidt-Chiari
D Oatley
(Resigned 24 September 2025)
S Paterson
(Appointed 24 September 2025)
Auditor
The auditor, Moore Kingston Smith LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
Small companies exemption
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
On behalf of the board
J Benton
Director
2 July 2026
Inuvi Diagnostics Limited
Directors' Responsibilities Statement
For the year ended 31 December 2025
Page 2
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Inuvi Diagnostics Limited
Independent Auditor's Report
To the Member of Inuvi Diagnostics Limited
Page 3
Opinion
We have audited the financial statements of Inuvi Diagnostics Limited (the 'company') for the year ended 31 December 2025 which comprise the Statement of Income and Retained Earnings, the Balance Sheet and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Inuvi Diagnostics Limited
Independent Auditor's Report
To the Member of Inuvi Diagnostics Limited (Continued)
Page 4
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the Directors' Report has been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Directors' Report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit; or
the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the Directors' Report and from the requirement to prepare a Strategic Report.
Responsibilities of directors
As explained more fully in the Directors' Responsibilities Statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Inuvi Diagnostics Limited
Independent Auditor's Report
To the Member of Inuvi Diagnostics Limited (Continued)
Page 5
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
As part of an audit in accordance with ISAs (UK) we exercise professional judgement and maintain professional scepticism throughout the audit. We also:
Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purposes of expressing an opinion on the effectiveness of the company’s internal control.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors.
Conclude on the appropriateness of the directors’ use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the company to cease to continue as a going concern.
Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
Inuvi Diagnostics Limited
Independent Auditor's Report
To the Member of Inuvi Diagnostics Limited (Continued)
Page 6
Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.
The objectives of our audit in respect of fraud, are; to identify and assess the risks of material misstatement of the financial statements due to fraud; to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud, through designing and implementing appropriate responses to those assessed risks; and to respond appropriately to instances of fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with both management and those charged with governance of the company.
Our approach was as follows:
We obtained an understanding of the legal and regulatory requirements applicable to the company and considered that the most significant are the Companies Act 2006, UK financial reporting standards as issued by the Financial Reporting Council, and UK taxation legislation.
We obtained an understanding of how the company complies with these requirements by discussions with management and those charged with governance.
We assessed the risk of material misstatement of the financial statements, including the risk of material misstatement due to fraud and how it might occur, by holding discussions with management and those charged with governance.
We inquired of management and those charged with governance as to any known instances of non-compliance or suspected non-compliance with laws and regulations.
Based on this understanding, we designed specific appropriate audit procedures to identify instances of non-compliance with laws and regulations. This included making enquiries of management and those charged with governance and obtaining additional corroborative evidence as required.
There are inherent limitations in the audit procedures described above. We are less likely to become aware of instances of non-compliance with laws and regulations that are not closely related to events and transactions reflected in the financial statements. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.
This report is made solely to the company's member in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's member those matters we are required to state to the member in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's member, for our audit work, for this report, or for the opinions we have formed.
Karen Wardell
Senior Statutory Auditor
for and on behalf of Moore Kingston Smith LLP
2 July 2026
Chartered Accountants
Statutory Auditor
Orbital House
20 Eastern Road
Romford
Essex
RM1 3PJ
Inuvi Diagnostics Limited
Statement of Income and Retained Earnings
For the year ended 31 December 2025
Page 7
2025
2024
Notes
£
£
Turnover
9,810,667
8,282,133
Cost of sales
(4,498,957)
(3,716,609)
Gross profit
5,311,710
4,565,524
Administrative expenses
(3,087,860)
(2,639,711)
Operating profit
2,223,850
1,925,813
Interest payable and similar expenses
(80)
Profit before taxation
2,223,850
1,925,733
Tax on profit
3
(209,588)
(82,912)
Profit for the financial year
2,014,262
1,842,821
Retained earnings brought forward
8,014,221
6,171,400
Dividends
(7,800,000)
Retained earnings carried forward
2,228,483
8,014,221
The Profit and Loss Account has been prepared on the basis that all operations are continuing operations.
Inuvi Diagnostics Limited
Balance Sheet
As at 31 December 2025
Page 8
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
338,092
465,842
Current assets
Stock
314,000
286,000
Debtors
5
6,418,198
8,122,472
Cash at bank and in hand
226,535
18,136
6,958,733
8,426,608
Creditors: amounts falling due within one year
6
(5,025,405)
(806,260)
Net current assets
1,933,328
7,620,348
Total assets less current liabilities
2,271,420
8,086,190
Provisions for liabilities
(42,837)
(71,869)
Net assets
2,228,583
8,014,321
Capital and reserves
Called up share capital
8
100
100
Profit and loss reserves
2,228,483
8,014,221
Total equity
2,228,583
8,014,321
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 2 July 2026 and are signed on its behalf by:
J Benton
Director
Company Registration No. 11304862
Inuvi Diagnostics Limited
Notes to the Financial Statements
For the year ended 31 December 2025
Page 9
1
Accounting policies
Company information
Inuvi Diagnostics Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 10 Millars Brook Business Park, Molly Millars Lane, Wokingham, Berkshire, United Kingdom, RG41 2AD.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. In the period following the year end, forecasts were produced and approved by the directors which show the company can continue to operate for at least the next twelve months following the approval of the financial statements. Post year end trading has been reviewed by the directors and the company has grown revenues and continued to produce positive financial results. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Leasehold improvements
33% straight line
Medical equipment
33% straight line
Fixtures and fittings
33% straight line
Computers
33% straight line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
Inuvi Diagnostics Limited
Notes to the Financial Statements (Continued)
For the year ended 31 December 2025
1
Accounting policies
(Continued)
Page 10
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
1.6
Stock
Stock are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stock to their present location and condition.
Stock held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stock over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.7
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.8
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Inuvi Diagnostics Limited
Notes to the Financial Statements (Continued)
For the year ended 31 December 2025
1
Accounting policies
(Continued)
Page 11
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.9
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.10
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
1.11
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.12
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
Inuvi Diagnostics Limited
Notes to the Financial Statements (Continued)
For the year ended 31 December 2025
1
Accounting policies
(Continued)
Page 12
1.13
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
35
30
3
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
237,584
152,014
Adjustments in respect of prior periods
1,036
(57,267)
Total current tax
238,620
94,747
Deferred tax
Origination and reversal of timing differences
(29,032)
(11,835)
Total tax charge
209,588
82,912
Inuvi Diagnostics Limited
Notes to the Financial Statements (Continued)
For the year ended 31 December 2025
Page 13
4
Tangible fixed assets
Leasehold improvements
Plant and machinery etc
Total
£
£
£
Cost
At 1 January 2025
433,764
945,289
1,379,053
Additions
4,045
100,250
104,295
Disposals
(7,156)
(7,156)
At 31 December 2025
437,809
1,038,383
1,476,192
Depreciation and impairment
At 1 January 2025
382,320
530,891
913,211
Depreciation charged in the year
43,744
184,524
228,268
Eliminated in respect of disposals
(3,379)
(3,379)
At 31 December 2025
426,064
712,036
1,138,100
Carrying amount
At 31 December 2025
11,745
326,347
338,092
At 31 December 2024
51,444
414,398
465,842
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
1,432,347
956,169
Corporation tax recoverable
85,360
Amounts owed by group undertakings
4,712,855
6,826,765
Other debtors
10,913
35,847
Prepayments and accrued income
262,083
218,331
6,418,198
8,122,472
Inuvi Diagnostics Limited
Notes to the Financial Statements (Continued)
For the year ended 31 December 2025
Page 14
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
427,286
544,047
Amounts owed to group undertakings
4,238,260
Corporation tax
73,636
Other taxation and social security
67,872
52,758
Other creditors
218,351
209,455
5,025,405
806,260
7
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:
Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
42,837
71,869
2025
Movements in the year:
£
Liability at 1 January 2025
71,869
Credit to profit or loss
(29,032)
Liability at 31 December 2025
42,837
The deferred tax liability set out above is expected to reverse within 12 months and relates to accelerated capital allowances that are expected to mature within the same period.
8
Called up share capital
2025
2024
£
£
Ordinary share capital
Issued and fully paid
1,000,000 Ordinary shares of 0.01p each
100
100
100
100
Inuvi Diagnostics Limited
Notes to the Financial Statements (Continued)
For the year ended 31 December 2025
Page 15
9
Financial commitments, guarantees and contingent liabilities
Oaknorth Bank PLC holds a fixed and floating charge over the assets of the company, as the Company acts as guarantor for the bank loan taken out by the parent company, Inuvi Group Limited.
J Benton holds a fixed and floating charge over the assets of the company, as the Company acts as guarantor for the Loan Notes taken out by the parent company, Inuvi Group Limited.
Longacre Group Limited holds a fixed and floating charge over the assets of the company, as the Company acts as guarantor for the Loan Notes taken out by the parent company, Inuvi Group Limited.
10
Operating lease commitments
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2025
2024
£
£
Within one year
138,842
8,550
Between two and five years
337,087
14,250
475,929
22,800
11
Related party transactions
The company is a wholly owned subsidiary of Inuvi Group Limited (formerly Longacre MSS Group Limited) and has taken advantage of the exemption conferred by FRS 102 not to disclose transactions with Inuvi Group Limited (formerly Longacre MSS Group Limited) or other wholly owned subsidiaries within the group.
12
Parent company
The company is a wholly owned subsidiary of Inuvi Group Limited (formerly Longacre MSS Group Limited), a company incorporated in England and Wales.
Longacre Group Limited is the smallest and largest group to prepare consolidated financial statements which include these financial statements. Copies of the financial statements can be obtained from 1 Mercer Street, London, WC2H 9QJ.
2025-12-312025-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.100J BentonT WoolleyE G NicholsonE Schmidt-ChiariD OatleyS PatersonS Paterson113048622025-01-012025-12-3111304862bus:Director12025-01-012025-12-3111304862bus:Director22025-01-012025-12-3111304862bus:Director42025-01-012025-12-3111304862bus:CompanySecretaryDirector12025-01-012025-12-3111304862bus:CompanySecretary12025-01-012025-12-3111304862bus:Director32025-01-012025-12-3111304862bus:Director52025-01-012025-12-3111304862bus:Director62025-01-012025-12-3111304862bus:RegisteredOffice2025-01-012025-12-31113048622025-12-31113048622024-01-012024-12-3111304862core:RetainedEarningsAccumulatedLosses2024-12-3111304862core:RetainedEarningsAccumulatedLosses2023-12-3111304862core:ShareCapital2025-12-3111304862core:ShareCapital2024-12-3111304862core:RetainedEarningsAccumulatedLosses2025-12-3111304862core:RetainedEarningsAccumulatedLosses2024-12-31113048622024-12-3111304862core:ShareCapitalOrdinaryShareClass12025-12-3111304862core:ShareCapitalOrdinaryShareClass12024-12-3111304862core:ShareCapitalOrdinaryShares2025-12-3111304862core:ShareCapitalOrdinaryShares2024-12-3111304862core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3111304862core:LandBuildings2025-12-3111304862core:OtherPropertyPlantEquipment2025-12-3111304862core:LandBuildings2024-12-3111304862core:OtherPropertyPlantEquipment2024-12-3111304862core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3111304862core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3111304862core:CurrentFinancialInstruments2025-12-3111304862core:CurrentFinancialInstruments2024-12-3111304862core:LeaseholdImprovements2025-01-012025-12-3111304862core:PlantMachinery2025-01-012025-12-3111304862core:FurnitureFittings2025-01-012025-12-3111304862core:ComputerEquipment2025-01-012025-12-3111304862core:UKTax2025-01-012025-12-3111304862core:UKTax2024-01-012024-12-3111304862core:LandBuildings2024-12-3111304862core:OtherPropertyPlantEquipment2024-12-31113048622024-12-3111304862core:LandBuildings2025-01-012025-12-3111304862core:OtherPropertyPlantEquipment2025-01-012025-12-3111304862bus:OrdinaryShareClass12025-12-3111304862bus:OrdinaryShareClass12025-01-012025-12-3111304862bus:PrivateLimitedCompanyLtd2025-01-012025-12-3111304862bus:FRS1022025-01-012025-12-3111304862bus:Audited2025-01-012025-12-3111304862bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP